MeSH D014397 - pulmonary tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  |
| Ofloxacin | Ofloxacin |  | 2003-09-02 |  |  | |
| Glenmark Pharmaceuticals | Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  |
| Mylan | Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  |
| NATCO Pharma | Levofloxacin | Levofloxacin |  | 2011-06-20 |  |  |
| Rising Pharmaceuticals | Levofloxacin | Levofloxacin |  | 2010-12-20 |  |  |
| Johnson & Johnson | Ofloxacin | Floxin |  | 1990-12-28 |  |  |
| Levofloxacin | Levaquin |  | 1996-12-20 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
100%8/8
Phase 2
42%21/50
Phase 3
66%21/32
Approved: 11Overall Success rate: 28%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use